• Mifepristone (RU486) Experimental Workflows

  2026-09-18

  Mifepristone (RU486) provides a practical pharmacological switch for testing progesterone receptor-dependent biology in cancer and reproductive models. This guide combines dose planning, receptor-context controls, quantitative readouts, and troubleshooting strategies for more interpretable experiments.

• Methyl-β-cyclodextrin Protocol and QC Guide

  2026-09-17

  Methyl-β-cyclodextrin (SKU C6939) is a 98.00% reagent for controlled membrane cholesterol extraction and studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It is intended for scientific research only; concentration, exposure time, vehicle, and cell-model compatibility must be established empirically, and prepared solutions should not be stored long term.

• Human Sensory Neurons Model HSV-1 Latency

  2026-09-17

  Oh et al. developed a scalable human iPSC-derived sensory neuron system that reproduces major molecular and functional features of HSV-1 latency and supports chemically induced reactivation. The model provides a human-relevant platform for studying neuron-intrinsic latency mechanisms while clarifying the limitations of extrapolating from animal systems.

• Liproxstatin-1 HCl: Assay Logic

  2026-09-16

  Liproxstatin-1 HCl is examined here as a causal assay tool for separating ferroptosis from broader oxidative or apoptotic injury. The article connects its rescue phenotype with the mitochondrial calcium–GPX4 axis and explains how to interpret cellular and organ-injury results without overstating translational maturity.

• Dacarbazine in Translational Oncology

  2026-09-16

  A mechanistic and strategic framework for using Dacarbazine as a translational benchmark across DNA damage, experimental validation, competitive benchmarking, supportive care, and clinical research.

• MK-1775: Wee1 Kinase Inhibitor Workflows

  2026-09-15

  Build more informative MK-1775 experiments by separating growth arrest from cell killing, then pair Wee1 inhibition with DNA-damaging treatment in genetically defined models. This guide combines checkpoint pharmacology, time-resolved assay design, and troubleshooting for reproducible cancer research workflows.

• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-15

  Gao and colleagues developed M2 microglia-targeting lipid nanoparticles that deliver interleukin-10 mRNA to ischemic brain lesions and reinforce an anti-inflammatory feedback loop. In mouse stroke models, the approach reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, with evidence suggesting a therapeutic window extending to 72 hours after stroke.

• G007-LK: Tankyrase 1/2 Inhibitor Workflows

  2026-09-14

  G007-LK enables controlled interrogation of tankyrase-dependent Wnt/β-catenin signaling, β-catenin turnover, and cancer-cell growth. Its strongest use cases span APC-mutant colorectal models, reporter assays, degradasome biology, and a carefully bounded extension into Hippo/YAP research.

• Ferroptosis Research Beyond a Rescue Compound

  2026-09-14

  Liproxstatin-1 HCl is more than a ferroptosis rescue reagent: it can serve as a mechanistic control, pathway-positioning tool, and translational bridge between lipid peroxidation biology and acute organ injury research.

• CIH, Gut Microbiota, and Mitochondrial Apoptosis

  2026-09-13

  This study integrates gut microbiome profiling, metabolomics, and mitochondrial apoptosis measurements to examine how chronic intermittent hypoxia damages the lung. Its pharmacological comparison of Mdivi-1 and CCCP links altered fatty acid metabolism and dysbiosis with mitochondrial injury, while also defining important limits on causal interpretation.

• Selonsertib (GS-4997) for Stress-Pathway Research

  2026-09-12

  Selonsertib (GS-4997) gives researchers a selective way to test whether ASK1 stress signaling contributes to autophagy failure, steatosis, inflammation, and fibrosis. This workflow pairs pathway inhibition with flux, lipid, and insulin-signaling readouts instead of treating ASK1 as a presumed upstream driver.

• Z-YVAD-FMK for Reliable Caspase-1 Assays

  2026-09-11

  Learn how Z-YVAD-FMK (SKU A8955) can strengthen mechanistic interpretation in apoptosis assays, pyroptosis research, and inflammasome activation studies. This practical guide covers model selection, controls, formulation, data interpretation, and supplier reliability.

• Clodronate Liposomes: Macrophage Depletion Workflows

  2026-09-10

  Clodronate Liposomes provide a practical way to test whether macrophages are required for injury, repair, or drug response in vivo. This guide connects phagocytosis-mediated delivery and apoptosis induction in macrophages with controls, tissue-specific workflows, single-cell readouts, and troubleshooting for liver ischemia-reperfusion research.

• GPR35–KLF5 Control of Epithelial Repair

  2026-09-09

  The reference study identifies a tryptophan–kynurenine–kynurenic acid sensing system in which GPR35 detects mucosal damage and signals through KLF5 and PI3K–AKT–mTOR to coordinate intestinal epithelial proliferation and migration. These findings provide a mechanistic framework for interpreting repair, rather than inflammation alone, in ulcerative colitis research and DSS-based intestinal injury models.

• Liproxstatin-1 HCl Ferroptosis Workflow

  2026-09-09

  Liproxstatin-1 HCl provides nanomolar ferroptosis rescue for cell-based lipid peroxidation studies and translational injury models. This workflow shows how to improve compound handling, distinguish ferroptosis from apoptosis, and connect mitochondrial calcium signaling to practical assay design.

8519 records 6/568 page Previous Next First page 上5页 678910 下5页 Last page